Startups
GrayMatters Health is developing a non-invasive digital therapeutics for mental
disorders through volitional regulation of brain processes
disorders through volitional regulation of brain processes
Overview
Location
Israel, Haifa District, Haifa
Employees
11-50
Total raised
$10M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 13, 2023 | Where We Are Investing Now: Next-Gen Neurotech | Photo by Yan Krukau In a world awash in stress, neurotech that lifts mood, diminishes anxiety, deepens positive behavior and otherwise benefits individuals is supremely important. Even so, in terms of investment, this category faces tough ... |
| Oct 2, 2022 | Nurturing our Neuroscience Focus | Photo by Priyanka Singh on Unsplash Clearly, the ability to read, stimulate, or alter the patterns of the brain is core to the concept of delightful moments. Whether through relief from anxiety or stress, creation of calm or comfort, initi... |
| Jan 12, 2022 | GrayMatters Health Raises $10M for Biomarker-Based PTSD Therapeutics | What You Should Know: – GrayMatters Health (GMH), a company set to change the standards of mental health care with biomarker-based therapeutics, beginning with PTSD raises $10 million in Series A funding round led by Otsuka Medical Devices ... |
| Jul 6, 2020 | Inception with Oded Kraft, CEO of Gray Matters | Oded Kraft is CEO of Gray Matters, an adjunct to standard of care digital therapeutics solution for treating mental and neurological disorders. In this episode, Oded talks about how GrayMatters is using this revolutionary technology to prov... |
| Jun 15, 2020 | COVID-19 Edition: How We Manage Our Portfolio: Why It Remains Strong During Market Corrections (And Apparently Pandemics) | When COVID-19 hit, it hit hard. Who would have imagined the Federal Reserves slashing interest rates down to zero to salve a dead stopped economy? Or imagined a worldwide lockdown? The modern world has, literally, never seen anything like t... |
| COVID-19 Edition: How We Manage Our Portfolio: Why It Remains Strong During Market Corrections (And Apparently Pandemics) | Photo by Micheile Henderson on Unsplash When COVID-19 hit, it hit hard. Who would have imagined the Federal Reserves slashing interest rates down to zero to salve a dead stopped economy? Or imagined a worldwide lockdown? The modern world h... | |
| Inception with Oded Kraft, CEO of Gray Matters | Oded Kraft is CEO of Gray Matters, an adjunct to standard of care digital therapeutics solution for treating mental and neurological disorders. In this episode, Oded talks about how GrayMatters is using this revolutionary technology to prov... |
Reviews 0
FAQ about GrayMatters Health
How much funding has GrayMatters Health raised?
GrayMatters Health has raised $10M in total across 1 funding round.
What has the press written about GrayMatters Health?
Parsers VC has collected 8 articles mentioning GrayMatters Health, among them “Where We Are Investing Now: Next-Gen Neurotech” (Apr 13, 2023) and “Nurturing our Neuroscience Focus” (Oct 2, 2022).
Is GrayMatters Health still active?
Yes, GrayMatters Health is active; its latest activity on Parsers VC dates from Apr 13, 2023.